-
FDA approves expanded use of Astella's Cresemba
Cresemba is the only azole antifungal therapy approved for pediatric patients affected by these serious, potentially life-threatening infections. -
Amneal, BIAL ink U.S. licensing agreement for Ongentys
Ongentys (opicapone) is an adjunctive therapy for the treatment of Parkinson’s disease.